Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Sudden cardiac death (SCD) is a leading cause of death. The implantable cardioverter-defibrillator (ICD) is an established therapy to prevent SCD in patients with prior ventricular tachycardia (VT) or ventricular fibrillation (VF)....

Descripción completa

Detalles Bibliográficos
Autores principales: Noordman, A B P, Rienstra, M, Blaauw, Y, Mulder, B A, Maass, A H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
14.2 - Implantable Cardioverter-Defibrillator (ICD)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207291/
http://dx.doi.org/10.1093/europace/euad122.413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207291/
http://dx.doi.org/10.1093/europace/euad122.413

Ejemplares similares